Please login to the form below

Not currently logged in
Email:
Password:

Xiaflex

This page shows the latest Xiaflex news and features for those working in and with pharma, biotech and healthcare.

Endo tries to ride out Valeant with $15.7bn bid for Salix

Endo tries to ride out Valeant with $15.7bn bid for Salix

a $2.6bn deal that added specialty medicine Xiaflex for fibrotic conditions affecting the fingers and penis. .

Latest news

  • Endo to acquire Auxilium for $2.6bn Endo to acquire Auxilium for $2.6bn

    Auxilium's lead product is Xiaflex (collagenase clostridium histolyticum), which is approved in Europe for the treatment of Dupuytren's contracture, a condition that causes one or more fingers to bend ... We intend to leverage Auxilium's leading presence

  • Endo's $2.2bn bid for Auxilium Pharma could thwart QLT deal Endo's $2.2bn bid for Auxilium Pharma could thwart QLT deal

    Auxilium has 12 approved products in its portfolio, including a range of testosterone supplements headed by Testim Gel, as well as Xiaflex (collagenase clostridium histolyticum) for Dupuytren's contracture - a condition ... While Auxilium's entire

  • Auxilium's Xiaflex cleared in US for erection disorder Auxilium's Xiaflex cleared in US for erection disorder

    FDA approval to treat Peyronie's disease. The US Food and Drug Administration (FDA) cleared Auxilium Pharmaceutical's Xiaflex product to treat Peyronie's disease, a condition that causes painful curvature ... The company has since signed a deal with

  • Extending the arsenal

    XIAFLEX (Auxilium Pharmaceuticals). Dupuytren's contracture. US. Capsaicin dermal patch. Qutenza (NeurogesX).

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics